 |
recombinant, non-pathogenic poliovirus:rhinovirus chimera that consists of the genome of the live attenuated poliovirus serotype 1 vaccine with its cognate IRES element replaced with that of HRV2 |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-26 00:00:00 |
| Sponsor | Istari Oncology, Inc.;Duke University Medical Center, 177 MSRB, Box 3156;Durham, North Carolina, 27710 |
Related Access Program